Utah Retirement Systems’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,800
| Closed | -$202K | – | 976 |
|
|
2024
Q4 | $202K | Hold |
4,800
| – | – | ﹤0.01% | 956 |
|
|
2024
Q3 | $267K | Buy |
+4,800
| New | +$267K | ﹤0.01% | 917 |
|
|
2024
Q2 | – | Sell |
-4,300
| Closed | -$201K | – | 994 |
|
|
2024
Q1 | $201K | Hold |
4,300
| – | – | ﹤0.01% | 940 |
|
|
2023
Q4 | $206K | Buy |
+4,300
| New | +$206K | ﹤0.01% | 956 |
|
|
2022
Q3 | – | Sell |
-3,400
| Closed | -$203K | – | 976 |
|
|
2022
Q2 | $203K | Hold |
3,400
| – | – | ﹤0.01% | 960 |
|
|
2022
Q1 | $247K | Hold |
3,400
| – | – | ﹤0.01% | 938 |
|
|
2021
Q4 | $286K | Hold |
3,400
| – | – | ﹤0.01% | 922 |
|
|
2021
Q3 | $307K | Buy |
3,400
+100
| +3% | +$9.03K | ﹤0.01% | 899 |
|
|
2021
Q2 | $315K | Buy |
+3,300
| New | +$315K | ﹤0.01% | 904 |
|